PHILRX Trademark

Trademark Overview

On Wednesday, March 4, 2020, a trademark application was filed for PHILRX with the United States Patent and Trademark Office. The USPTO has given the PHILRX trademark a serial number of 88821161. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 16, 2023. This trademark is owned by Phil, Inc.. The PHILRX trademark is filed in the Communication Services category with the following description:

Communication services, namely, electronic transmission of data and documents among users of computers and electronic devices; electronic transmission of data and documents in the fields of pharmaceutical distribution and prescription delivery
philrx

General Information

Serial Number88821161
Word MarkPHILRX
Filing DateWednesday, March 4, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements

Goods and ServicesCommunication services, namely, electronic transmission of data and documents among users of computers and electronic devices; electronic transmission of data and documents in the fields of pharmaceutical distribution and prescription delivery
Pseudo MarkPHIL RX

Classification Information

International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateTuesday, March 10, 2020
Primary Code038
First Use Anywhere DateWednesday, September 29, 2021
First Use In Commerce DateWednesday, September 29, 2021

Trademark Owner History

Party NamePhil, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NamePhil, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Thursday, February 16, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 16, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 16, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Monday, February 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 7, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, February 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 20, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 18, 2022USE AMENDMENT FILED
Tuesday, January 18, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, April 21, 2021DIVISIONAL REQUEST RECEIVED
Monday, November 30, 2020TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 8, 2021ASSIGNED TO LIE
Monday, March 1, 2021ASSIGNED TO LIE
Monday, November 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 29, 2020NON-FINAL ACTION E-MAILED
Friday, May 29, 2020NON-FINAL ACTION WRITTEN
Friday, May 22, 2020ASSIGNED TO EXAMINER
Tuesday, March 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 7, 2020NEW APPLICATION ENTERED

Related Keywords

philrx electronic data documents transmission pharmaceutical fields distribution delivery prescription devices